Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Cancer"
DOI: 10.1038/bjc.2016.387
Abstract: Background:VeriStrat is a blood-based proteomic test with predictive and prognostic significance in second-line treatments for non-small cell lung cancer (NSCLC). This trial was designed to investigate the role of VeriStrat in first-line treatment of advanced… read more here.
Keywords: non squamous; first line; veristrat; test ... See more keywords